About
Patient Care
Education
Research
Community
Friday, September 6& Saturday, September 7, 2024
In-personArnold and Mabel Beckman Center 100 Academy Way, Irvine, CA 92617
PLEASE NOTE: You must complete a brief evaluation of our event in order to receive your CME certificate. This will be uploaded following the event.
Please note that this evaluation must be completed and submitted online by November 12, 2024. This is the only way to confirm your attendance, which is required in order to receive CME credit.
CME CERTIFICATION EVALUATION link coming soon
2024 Colloquium Syllabus coming soon
Accreditation Statement: The University of California, Irvine School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement: The University of California, Irvine School of Medicine designates this live activity has been approved for AMA PRA Category 1 Credits. Physicians should claim only the credit that is commensurate with the extent of their participation in the activity.
Instructors: Soroosh Behshad, MD; Sam Garg, MD; Sanjay Kedhar, MD; Olivia Lee, MD; Matthew Wade, MD
Baruch D. (Barry) Kuppermann, MD, PhD
Moderator: Barry Kuppermann, MD, PhD
What is home OCT and how can it help patients with wet AMD? Speaker: Christina Weng, MD, MBA
Ellipsoid zone: the new FDA-approved clinical endpoint Speaker: Andrew Browne, MD
Radiation retinopathy: current management and future strategies Speaker: Kapil Mishra, MD
Moderator: Stephanie Lu, MD
Panel discussion: Topics: wet and dry AMD; diabetic retinopathy, vein occlusions, uveitis Panel: Andrew Browne, MD, PhD; Barry Kuppermann, MD, PhD; Christina Weng, MD; Mitul Mehta, MD; Mohammad Riazi, MD; Stephanie Lu, MD
Gavin Herbert Lecture: How gene therapy could transform retinal care Speaker: Christina Weng, MD, MBA
Moderator: Sanjay Kedhar, MD; Vivek Patel, MD
The wild west: Neuro-ophthalmology + Uveitis Panel: Wade Crow, MD; Lilangi Ediriwickrema, MD; Sanjay Kedhar, MD; Olivia Lee, MD; Vivek Patel, MD; Sam Spiegel, MD; Christina Weng, MD
Moderator: Soroosh Behshad, MD
Refractive surgery showdown: LASIK, SMILE, ICL, and more Panel: Soroosh Behshad, MD; Daniel Chang, MD; Sam Garg, MD; Matthew Wade, MD
Instructors: Soroosh Behshad, MD; Daniel Chang, MD; Sam Garg, MD; Sanjay Kedhar, MD; Olivia Lee, MD; Matthew Wade, MD
Moderator: Matthew Wade, MD
Pearls and pitfalls from learning the iris implant Speaker: Matthew Wade, MD
IOL optics and range of focus IOLs: How to approach new technology Speaker: Daniel Chang, MD
Ocular surface transplantation - The Gavin Herbert Eye Institute Experience Speaker: Soroosh Behshad, MD
The only talk on dry eye and blepharitis you need to hear Speaker: Sam Garg, MD
Losartan for corneal scars - does it really work? Speaker: Olivia Lee, MD
Steinert Memorial Lecture: A paradigm for presbyopia correction: starting with the why Speaker: Daniel Chang, MD
Moderator: Vivek Patel, MD
Cornea | Sam Garg, MD
Neuro-ophthalmology | Speaker: Sam Spiegel, MD
Retina | Speaker: Andrew Browne, MD, PhD
Pediatrics | Speaker: Charlotte Gore, MD
Glaucoma | Speaker: Andrew Smith, MD
Cataract | Daniel Chang, MD
Oculoplastics | Speaker: Seanna Grob, MD
Refractive | Matthew Wade, MD
Uveitis | Speaker: Sanjay Kedhar, MD
Lilangi Ediriwickrema, MD
Introduction to clinical informatics Speaker: Sally Baxter, MD, MSc
Moderator: Jeremiah Tao, MD
Brow lifting techniques and tips: improving vision and facial rejuvenation | Speaker: Lilangi Ediriwickrema, MD
Insights into treatment of unresectable periocular tumors | Speaker: Seanna Grob, MD
Pearls for lower eyelid reconstruction | Speaker: Jeremiah Tao, MD
Biostatistics for the ophthalmologist Speaker: Sally Baxter, MD, MSc
Moderator: Austin Fox, MD
Drug delivery systems for glaucoma | Speaker: Ken Lin, MD
Principles of managing the conjunctiva in glaucoma surgery | Speaker: Andrew Smith, MD
State of the bleb | Speaker: Austin Fox, MD
Cannabis and glaucoma: exporing therapeutic potential and challenges | Speaker: Sameh Mosaed, MD
Moderator: Sam Garg, MD
Cataract | Speaker: Daniel Chang, MD
Retina | Speaker: Christina Weng, MD
General | Speaker: Sally Baxter, MD, MSc
Strabismus | Speaker: Donny Suh, MD
Barry Kuppermann, MD, PhD
Program Chair
Parking is free
Sandoz
Sandoz is the leading global provider of off-patent medicines. These generic and biosimilar medicines are more affordable than reference medicines. With a comprehensive portfolio of around 1,500 products covering most major therapeutic areas and available in over 100 countries, we make a real difference for patients and healthcare systems worldwide.
CorneaGen
CorneaGen is a mission-driven company committed to transforming how corneal surgeons treat and care for the cornea. Based in Seattle, the company is innovating the next generation of cornea care, from new medical devices and biologics to therapeutics and interventions. CorneaGen supports corneal surgeons and their patients with a spectrum of services, including the latest products, delivery of the highest-quality tissue, surgeon education, and advocacy for patient access and reimbursement policies.
Tarsus Pharmaceuticals, Inc
Tarsus Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company that applies proven science and new technology to revolutionize treatment for patients, starting with eye care. It is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care, dermatology, and infectious disease prevention. The company is studying two investigational medicines in clinical trials. Its lead product candidate, XDEMVEY, is a novel therapeutic being studied in a second Phase 3 pivotal trial for the treatment of Demodex blepharitis. XDEMVEY is also being developed for the treatment of Meibomian Gland Disease. Tarsus is developing TP-05, an oral, non-vaccine therapeutic for the prevention of Lyme disease, which is currently being studied in a Phase 1 clinical trial.
Genentech
Genentech, a member of the Roche Group, has more than 40 years of experience in the field of biotechnology. Genentech is researching and developing new treatments for people living with a range of eye diseases that cause significant visual impairment and blindness, including wet age-related macular degeneration (AMD), diabetic macular edema (DME), diabetic retinopathy (DR), geographic atrophy (GA), and other retinal diseases.
Alcon
We Are Alcon We help the world see, look and feel better. And after our first 70 years, we are just getting started. Discover our story. Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning more than seven decades, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 20,000 associates are enhancing the quality of life through innovative products, partnerships with eye care professionals and programs that advance access to quality eye care.
Click registration button to see further details for
Event Contact:
Dana Collinson | 949-824-7243 | dana.collinson@hs.uci.edu